Grifols, S.A. - American Depositary Shares - Çeyreklik Bilanço (NASDAQ:GRFS)

Grifols, S.A. - American Depositary Shares

Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care.

GRFS

Financials

Grifols, S.A. - American Depositary Shares

Haberler

Can Asceniv Help ADMA Navigate the Current IG Market Challenges?

Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?

Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?

Grifols’ün 1Ç 2026 sonuçları karışık, HBK beklentiyi aştı

Grifols’ün 1Ç 2026 sonuçları karışık sinyaller verdi

Will the Label Expansion of Asceniv Boost ADMA's Top-Line Growth?

Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?

Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?

Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns?

ADMA Crashes 42.5% YTD: Right Time to Buy the Stock?

Is ADMA Poised for Margin Growth and Supply Expansion in 2026?

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?